PT86879A - Synergistic interplay of lymphokines and rnas - Google Patents

Synergistic interplay of lymphokines and rnas

Info

Publication number
PT86879A
PT86879A PT86879A PT8687988A PT86879A PT 86879 A PT86879 A PT 86879A PT 86879 A PT86879 A PT 86879A PT 8687988 A PT8687988 A PT 8687988A PT 86879 A PT86879 A PT 86879A
Authority
PT
Portugal
Prior art keywords
lymphokines
dsrna
human
disorders
rnas
Prior art date
Application number
PT86879A
Other languages
English (en)
Other versions
PT86879B (pt
Inventor
William A Carter
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of PT86879A publication Critical patent/PT86879A/pt
Publication of PT86879B publication Critical patent/PT86879B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Plant Substances (AREA)
PT86879A 1987-03-03 1988-03-02 Processo para a preparacao de uma composicao farmaceutica utilizando a interaccao sinergistica entre linfoquinas e arns de dupla cadeia PT86879B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2136887A 1987-03-03 1987-03-03

Publications (2)

Publication Number Publication Date
PT86879A true PT86879A (pt) 1988-04-01
PT86879B PT86879B (pt) 1992-05-29

Family

ID=21803798

Family Applications (1)

Application Number Title Priority Date Filing Date
PT86879A PT86879B (pt) 1987-03-03 1988-03-02 Processo para a preparacao de uma composicao farmaceutica utilizando a interaccao sinergistica entre linfoquinas e arns de dupla cadeia

Country Status (19)

Country Link
EP (1) EP0281380B1 (pt)
JP (1) JPH0713024B2 (pt)
KR (1) KR960008009B1 (pt)
CN (1) CN1054509C (pt)
AT (1) ATE130760T1 (pt)
AU (2) AU1256588A (pt)
CA (1) CA1336810C (pt)
DE (1) DE3854726T2 (pt)
DK (1) DK113188A (pt)
ES (1) ES2082749T3 (pt)
FI (1) FI880961A7 (pt)
IE (1) IE75895B1 (pt)
IL (1) IL85603A (pt)
NO (1) NO880946L (pt)
NZ (1) NZ223720A (pt)
PH (1) PH24467A (pt)
PT (1) PT86879B (pt)
RU (1) RU1836103C (pt)
ZA (1) ZA881512B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA881639B (en) * 1987-03-23 1989-02-22 Hem Res Inc Treatment of human viral infection by dsrna combined with viral inhibitors
ES2076259T3 (es) * 1989-06-30 1995-11-01 American Cyanamid Co Metodo para el tratamiento de enfermedades infecciosas activando celulas fagociticas en animales.
TW589189B (en) 1997-08-04 2004-06-01 Scras Kit containing at least one double-stranded RNA combined with at least one anti-viral agent for therapeutic use in the treatment of a viral disease, notably of viral hepatitis
FR2768344B1 (fr) * 1997-08-26 2001-02-16 Scras Produit comprenant au moins un arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique dans le traitement d'une maladie virale
FR2768345B1 (fr) * 1997-09-17 2001-05-04 Scras Produit comprenant au moins un arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique dans le traitement d'une maladie virale, notamment d'une hepatite virale
FR2766715B1 (fr) * 1997-08-04 2001-02-16 Scras Produit comprenant au moins de l'arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique simultanee, separee ou etalee dans le temps, dans le traitement d'une maladie virale
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
CN101818145A (zh) 1998-03-20 2010-09-01 联邦科学和工业研究组织 控制基因表达
AU776150B2 (en) 1999-01-28 2004-08-26 Medical College Of Georgia Research Institute, Inc. Composition and method for (in vivo) and (in vitro) attenuation of gene expression using double stranded RNA
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
US20020132257A1 (en) 2001-01-31 2002-09-19 Tony Giordano Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
WO2006054129A1 (en) * 2004-11-19 2006-05-26 Institut Gustave Roussy Improved treatment of cancer by double-stranded rna
EP2116602A1 (en) 2008-05-07 2009-11-11 Institut Gustave Roussy Combination products for treating cancer
WO2011109833A2 (en) 2010-03-05 2011-09-09 President And Fellows Of Harvard College Induced dendritic cell compositions and uses thereof
CN106794246B (zh) 2014-08-08 2021-10-15 OncoQuest制药有限公司 肿瘤抗原特异性抗体和tlr3刺激以增强检查点干扰癌症疗法的性能
TW202308629A (zh) 2021-04-28 2023-03-01 法商Ｅｎｙｏ製藥公司 使用fxr激動劑作為組合治療以增強tlr3激動劑之療效

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0113162B1 (en) * 1982-09-16 1989-07-19 Hem Research, Inc. Anti-proliferative action of dsnras on tumor cells
CA1326450C (en) * 1985-08-26 1994-01-25 William A. Carter Modulation of aids virus-related events by double stranded rnas (dsrnas)

Also Published As

Publication number Publication date
IL85603A (en) 1993-05-13
EP0281380A3 (en) 1989-09-27
AU1256588A (en) 1988-09-01
NO880946L (no) 1988-09-05
CN1054509C (zh) 2000-07-19
PT86879B (pt) 1992-05-29
EP0281380A2 (en) 1988-09-07
JPS63295514A (ja) 1988-12-01
DE3854726T2 (de) 1996-07-25
RU1836103C (ru) 1993-08-23
NO880946D0 (no) 1988-03-03
FI880961L (fi) 1988-09-04
KR880010776A (ko) 1988-10-24
IL85603A0 (en) 1988-08-31
AU1618992A (en) 1992-08-06
NZ223720A (en) 1991-07-26
IE880588L (en) 1988-09-03
DE3854726D1 (de) 1996-01-11
IE75895B1 (en) 1997-09-24
ATE130760T1 (de) 1995-12-15
CN1032296A (zh) 1989-04-12
ES2082749T3 (es) 1996-04-01
JPH0713024B2 (ja) 1995-02-15
FI880961A0 (fi) 1988-03-02
PH24467A (en) 1990-07-18
FI880961A7 (fi) 1988-09-04
ZA881512B (en) 1988-11-30
CA1336810C (en) 1995-08-29
DK113188A (da) 1988-09-04
KR960008009B1 (ko) 1996-06-19
DK113188D0 (da) 1988-03-02
EP0281380B1 (en) 1995-11-29

Similar Documents

Publication Publication Date Title
ZA881512B (en) Synergistic interplay of lymphokines and double-stranded rnas
ATE73347T1 (de) Antivirales immunotherapeutisches mittel und dessen herstellung.
OA08724A (fr) Treatment of human viral infections by dsRNA combined with viral inhibitors.
NZ226005A (en) Covalent conjugates of a human cytokine and a human immunoglobulin, processes for their manufacture and pharmaceutical compositions thereof
MY104069A (en) Therapeutic nucleosides
ES2036526T3 (es) Composiciones de interferon.
BR9007741A (pt) Protecao contra estados de choque subsequentes a lesoes por rnas de duplo filamento
EP0325018A3 (en) Rnase l inhibitor as a marker for virus infections
DE69106877D1 (de) Aus blaualgen hergestellte biologisch aktive verbindungen.
GR3024236T3 (en) Use of leukoregulin for the treatment of animals infected with an envelope-virus
SU1727820A1 (ru) Способ стимул ции сперматогенеза у быков
IT1212737B (it) Derivati pirimidinici ad azione antivirale.
ES2007094A6 (es) Procedimiento para la preparacion de 3 -c- ciano-2,3 -didesoxinucleosido.
FR2047884A1 (en) Anti-leukopenic partially-lysed thymus - extract
ZA881639B (en) Treatment of human viral infection by dsrna combined with viral inhibitors
JO1708B1 (en) The use of trinitrobenzene or cochineal acid in the treatment of cancer or genital diseases

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19911129

MM3A Annulment or lapse

Effective date: 20050530